Dyslipidemias
2 competing products in clinical development for Dyslipidemias.
Pipeline by Phase
Phase 11
Approved1
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mg | Yuhan | Approved | Completed | 43 |
| LY3202328 + Placebo + Atorvastatin + Simvastatin | Eli Lilly | Phase 1 | Completed | 29 |